Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : TAVA Technologies (TAVA-NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (27941)	2/12/1999 8:38:00 AM
From: Manzanillo	Read Replies (2) \| Respond to of 31646

<<And I've been correct for two years. The fact the stock price doesn't reflect it yet is irrelevant.>> In other words, in your own mind you can be "correct" and broke. <<I made a bundle with ZONA>> <<I doubt it.>>BW Bought in early January of 1997 at 9 3/8 sold in September at 35. I was happy with that. Look at Trade Oex posts on Motley Fool. <<and am sure will do the same with TAVA>> Why? Were you intelligent enough to short TAVA when it was 14?>> No but I was smart, or lucky enough, to buy it in October for 2 7/8 and in November for 4 3/8. I'm not losing money and don't intend to. I think this will turn into a very profitable investment for me. <<I shorted Zonagen at 35...I also shorted Zonagen at 15, because Zonagen is not worth 15...and it certainly is not worth 35. By the time FDA rejection rolls around it will be too late to initiate a position>> The approximate dates for FDA approval or rejection are known in advance. It was not too smart to short the stock at 15, after their deal with Scheering was known, based on a possible rejection by the FDA that was many months away. And that is why, if you shorted it at 15 as you say, you are losing 100% now that the stock is near 30.